MPM BioImpact LLC Diversified Active

CIK: 0001687078 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value ($000): $374,603 (100.0% shares, 0.0% debt)

Holdings (32)

CGEM Cullinan Oncology, Inc. 18.5%

Value ($000) $69,217 Shares 7,648,268 Est. Cost $40.60 Unrealized -74.3%

OLMA Olema Pharmaceuticals, Inc. 6.1%

Value ($000) $22,942 Shares 1,857,681 Est. Cost $9.16 Unrealized +11.3%

GERN Geron Corporation 6.1%

Value ($000) $22,710 Shares 10,712,481 Est. Cost $1.65 Unrealized +64.7%

— Repare Therapeutics, Inc. 5.3%

Value ($000) $19,809 Shares 1,639,849 Est. Cost $31.02 Unrealized —

— iTeos Therapeutics, Inc. 5.1%

Value ($000) $19,118 Shares 1,745,943 Est. Cost $24.67 Unrealized —

NTLA Intellia Therapeutics, Inc. 4.6%

Value ($000) $17,221 Shares 544,639 Est. Cost $77.45 Unrealized -49.9%

MLTX Moonlake Immunotherapeutics 4.5%

Value ($000) $16,769 Shares 294,190 Est. Cost $26.91 Unrealized +105.2%

IOVA Iovance Biotherapeutics Inc 4.0%

Value ($000) $14,958 Shares 3,287,397 Est. Cost $9.98 Unrealized -34.6%

CRNX Crinetics Pharmaceuticals Inc. 3.8%

Value ($000) $14,247 Shares 479,053 Est. Cost $21.22 Unrealized -2.9%

INSM Insmed Incorporated 3.6%

Value ($000) $13,318 Shares 527,458 Est. Cost $19.24 Unrealized +18.9%

GPCR STRUCTURE THERAPEUTICS INC 3.1%

Value ($000) $11,635 Shares 230,761 Est. Cost $50.42 Unrealized —

— Verve Therapeutics, Inc 3.0%

Value ($000) $11,376 Shares 857,940 Est. Cost $30.36 Unrealized —

RLAY Relay Therapeutics Inc. 3.0%

Value ($000) $11,371 Shares 1,352,133 Est. Cost $17.41 Unrealized -38.2%

RGNX REGENXBIO Inc. 2.9%

Value ($000) $10,810 Shares 656,718 Est. Cost $29.05 Unrealized -37.6%

— CYMABAY THERAPEUTICS INC 2.4%

Value ($000) $9,107 Shares 610,770 Est. Cost $14.91 Unrealized —

— Karuna Therapeutics Inc 2.4%

Value ($000) $8,997 Shares 53,210 Est. Cost $216.85 Unrealized —

FOLD Amicus Therapeutics Inc. 2.3%

Value ($000) $8,708 Shares 716,139 Est. Cost $11.28 Unrealized +14.4%

RVMD Revolution Medicines, Inc. 2.0%

Value ($000) $7,568 Shares 273,408 Est. Cost $26.97 Unrealized +10.0%

XERS Xeris Biopharma Holdings Inc 2.0%

Value ($000) $7,418 Shares 3,987,967 Est. Cost $2.55 Unrealized -10.0%

— Avadel Pharmaceuticals PLC 1.8%

Value ($000) $6,842 Shares 664,224 Est. Cost $13.88 Unrealized —

AXSM Axsome Therapeutics, Inc. 1.7%

Value ($000) $6,541 Shares 93,586 Est. Cost $64.41 Unrealized +16.1%

MDGL Madrigal Pharmaceuticals inc 1.6%

Value ($000) $5,967 Shares 40,859 Est. Cost $136.15 Unrealized +38.2%

KALV Kalvista Pharmaceuticals Inc 1.5%

Value ($000) $5,566 Shares 577,958 Est. Cost $9.22 Unrealized +10.8%

HOWL Werewolf Therapeutics, Inc. 1.4%

Value ($000) $5,110 Shares 2,388,011 Est. Cost $13.70 Unrealized -79.9%

TVTX Travere Therapeutics Inc. 1.3%

Value ($000) $4,942 Shares 552,846 Est. Cost $18.49 Unrealized -23.7%

— MORPHIC HOLDING INC 1.2%

Value ($000) $4,582 Shares 200,000 Est. Cost $22.91 Unrealized —

ADAPY Adaptimmune Therapeutics plc 1.1%

Value ($000) $3,975 Shares 5,095,912 Est. Cost $0.93 Unrealized —

VRDN Viridian Therapeutics Inc 1.0%

Value ($000) $3,917 Shares 255,323 Est. Cost $25.65 Unrealized -25.6%

PHAT Phathom Pharmaceuticals inc 1.0%

Value ($000) $3,602 Shares 347,332 Est. Cost $14.37 Unrealized -4.6%

VKTX VIKING THERAPEUTICS INC 1.0%

Value ($000) $3,598 Shares 325,000 Est. Cost $14.30 Unrealized 0.0%

— Inozyme Pharma Inc. 0.4%

Value ($000) $1,373 Shares 326,921 Est. Cost $7.14 Unrealized —

— Harpoon Therapeutics, Inc. 0.3%

Value ($000) $1,288 Shares 319,670 Est. Cost $4.03 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CGEM	Cullinan Oncology, Inc.	7,648,268	$69,217	18.5%	$40.60	-74.3%	Common	230031106
OLMA	Olema Pharmaceuticals, Inc.	1,857,681	$22,942	6.1%	$9.16	+11.3%	Common	68062P106
GERN	Geron Corporation	10,712,481	$22,710	6.1%	$1.65	+64.7%	Common	374163103
—	Repare Therapeutics, Inc.	1,639,849	$19,809	5.3%	$31.02	—	Common	760273102
—	iTeos Therapeutics, Inc.	1,745,943	$19,118	5.1%	$24.67	—	Common	46565G104
NTLA	Intellia Therapeutics, Inc.	544,639	$17,221	4.6%	$77.45	-49.9%	Common	45826J105
MLTX	Moonlake Immunotherapeutics	294,190	$16,769	4.5%	$26.91	+105.2%	Common	61559X104
IOVA	Iovance Biotherapeutics Inc	3,287,397	$14,958	4.0%	$9.98	-34.6%	Common	462260100
CRNX	Crinetics Pharmaceuticals Inc.	479,053	$14,247	3.8%	$21.22	-2.9%	Common	22663K107
INSM	Insmed Incorporated	527,458	$13,318	3.6%	$19.24	+18.9%	Common	457669307
GPCR	STRUCTURE THERAPEUTICS INC	230,761	$11,635	3.1%	$50.42	—	Common	86366E106
—	Verve Therapeutics, Inc	857,940	$11,376	3.0%	$30.36	—	Common	92539P101
RLAY	Relay Therapeutics Inc.	1,352,133	$11,371	3.0%	$17.41	-38.2%	Common	75943R102
RGNX	REGENXBIO Inc.	656,718	$10,810	2.9%	$29.05	-37.6%	Common	75901B107
—	CYMABAY THERAPEUTICS INC	610,770	$9,107	2.4%	$14.91	—	Common	23257D103
—	Karuna Therapeutics Inc	53,210	$8,997	2.4%	$216.85	—	Common	48576A100
FOLD	Amicus Therapeutics Inc.	716,139	$8,708	2.3%	$11.28	+14.4%	Common	03152W109
RVMD	Revolution Medicines, Inc.	273,408	$7,568	2.0%	$26.97	+10.0%	Common	76155X100
XERS	Xeris Biopharma Holdings Inc	3,987,967	$7,418	2.0%	$2.55	-10.0%	Common	98422E103
—	Avadel Pharmaceuticals PLC	664,224	$6,842	1.8%	$13.88	—	Common	05337M104
AXSM	Axsome Therapeutics, Inc.	93,586	$6,541	1.7%	$64.41	+16.1%	Common	05464T104
MDGL	Madrigal Pharmaceuticals inc	40,859	$5,967	1.6%	$136.15	+38.2%	Common	558868105
KALV	Kalvista Pharmaceuticals Inc	577,958	$5,566	1.5%	$9.22	+10.8%	Common	483497103
HOWL	Werewolf Therapeutics, Inc.	2,388,011	$5,110	1.4%	$13.70	-79.9%	Common	95075A107
TVTX	Travere Therapeutics Inc.	552,846	$4,942	1.3%	$18.49	-23.7%	Common	89422G107
—	MORPHIC HOLDING INC	200,000	$4,582	1.2%	$22.91	—	Common	61775R105
ADAPY	Adaptimmune Therapeutics plc	5,095,912	$3,975	1.1%	$0.93	—	Sponsored ADR	00653A107
VRDN	Viridian Therapeutics Inc	255,323	$3,917	1.0%	$25.65	-25.6%	Common	92790C104
PHAT	Phathom Pharmaceuticals inc	347,332	$3,602	1.0%	$14.37	-4.6%	Common	71722W107
VKTX	VIKING THERAPEUTICS INC	325,000	$3,598	1.0%	$14.30	0.0%	Common	92686J106
—	Inozyme Pharma Inc.	326,921	$1,373	0.4%	$7.14	—	Common	45790W108
—	Harpoon Therapeutics, Inc.	319,670	$1,288	0.3%	$4.03	—	Common	41358P205